Brief: 4D Molecular Therapeutics Q1 Net Income USD -47.972 Million
08/05/2025 21:05
May 08 (Reuters) - 4D Molecular Therapeutics Q1 revenue USD 14 thousand. Q1 operating income USD -53.621 million Q1 operating expenses USD 53.635 million Q1 basic EPS USD -0.86
Recent news on 4D Molecular Therapeutics
See all news4D Molecular Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
4D Molecular Therapeutics Q2 net loss widens
Brief: 4D Molecular Therapeutics Q2 Net Income USD -72.936 Million Vs. IBES Estimate USD -70.3 Million
4D Molecular Therapeutics Inc expected to post a loss of $1.02 a share - Earnings Preview
Brief: 4d Molecular Therapeutics Says 4D-150 Continues To Be Well Tolerated With No New Safety Findings